Mastijet Forte , mastitis treatment for cattle, 20 syringes

COMPOSITION:
Each 8 g syringe contains:
Active substances:
Tetracycline hydrochloride 200 mg
Neomycin (as neomycin sulfate) 250 mg
Bacitracin 2000 IU
Prednisolone 10 mg
Excipients:
Magnesium stearate
Liquid paraffin
Yellow oily suspension.

INDICATIONS:
Treatment of clinical and subclinical mastitis caused by bacteria (Staphylococcus aureus, Streptococcus dysgalactiae, Streptococcus uberis and Escherichia coli) sensitive to tetracycline, neomycin and bacitracin or combinations of these active substances in cows during the lactation period.

CONTRAINDICATIONS:
Do not use in cases of hypersensitivity to tetracycline, neomycin or bacitracin. Do not use the cleaning wipes on teats with visible unhealed wounds or cuts.

ADVERSE REACTIONS:
Very rare (1 animal in 10,000 animals treated, including isolated reports) hypersensitivity reactions have been reported.

TARGET SPECIES:
Cattle (lactating cows).

METHOD OF ADMINISTRATION:
Intramammary administration. Treatment consists of injecting the contents of one syringe into each affected quarter, repeated every 12 hours, with a maximum of four administrations.

RECOMMENDATIONS ON CORRECT ADMINISTRATION:
Before injecting the contents of the syringe, the udder should be milked completely. The teat and orifice should be cleaned and disinfected with the cleaning wipe provided with the product. Care should be taken not to contaminate the tip of the syringe. Break off the tip of the syringe and carefully insert approximately 5 mm or remove the entire cap and insert the entire length of the tip into the teat canal. Inject the entire contents of one syringe into each quarter.

WITHDRAWAL PERIOD:
Meat and offal: 14 days; milk: 8 milkings.

SPECIAL STORAGE PRECAUTIONS:
Keep out of the sight and reach of children. Do not use this veterinary medicinal product after the expiry date which is stated on the label after EXP. The expiry date refers to the last day of that month.

SPECIAL WARNINGS:
Special precautions for use in animals:
Due to the variability (temporal, geographical) in bacterial susceptibility when using the product, bacteriological sampling and susceptibility testing of microorganisms isolated from diseased animals is recommended. If this is not possible, therapy should be based on local epidemiological information on the susceptibility of the target bacteria. Use of the product deviating from the instructions provided in the SPC may increase the prevalence of bacteria resistant to the active substances and may decrease the effectiveness of the treatment due to the potential for cross-resistance. Official and local antimicrobial policies should be taken into account when using the product.
Special precautions to be taken by the person administering the veterinary medicinal product to animals:
People with known allergies to tetracycline, neomycin or bacitracin should avoid skin contact with the product. Tetracycline, neomycin and bacitracin may cause hypersensitivity (allergic) reactions following injection, inhalation or skin contact. Occasionally, allergic reactions to these substances may be serious. If you experience symptoms following exposure, such as skin irritation, seek medical advice and show this warning. Swelling of the face, lips or eyes or difficulty breathing are more serious symptoms and require urgent medical treatment.
Use during pregnancy and lactation:
The product is intended for use during lactation and pregnancy. Studies in laboratory animals have not shown teratogenic and/or embryotoxic effects.
Interactions with other medicinal products or other forms of interaction:
None known.
Overdose:
Not applicable.
Incompatibilities:
None known.

SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCTS OR WASTE MATERIALS, IF ANY:
Medicines should not be thrown away via wastewater or household waste. Ask your veterinarian or pharmacist for information on how to dispose of medicines no longer required. These measures will help to protect the environment.

SIZE:
Syringe x 8 g